Skip to content

Misoprostol vaginal tablet and Dinoprostone pessary for induction of labor at term ——propensity score matching method(PSM)

Misoprostol vaginal tablet and Dinoprostone pessary for induction of labor at term ——propensity score matching method(PSM)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095390
Enrollment
Unknown
Registered
2025-01-07
Start date
2024-10-22
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

induction of labor at term

Interventions

dinoprostone pessary group and misoprostol vaginal tablet group:Not applicable

Sponsors

Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: age > 18 years, >= 37 weeks, singleton, cephalocephaly, need to promote cervical ripening (Bishop < 6), parity < 3, non scarred uterus

Exclusion criteria

Exclusion criteria: who did not use misoprostol vaginal tablet or dinoprostone for induction of labor, contraindications to vaginal trial production, breech presentation, allergy to prostaglandins or severe asthma reaction, and incomplete data were exclude.

Design outcomes

Primary

MeasureTime frame
cesarean section rate;elivery 24 hours after medication;

Secondary

MeasureTime frame
hypercontractions,;whether other methods of induction need to be sequential;whether amniotic fluid fecal staining;whether intrapartum fever;whether episiotomy; whether severe perineal laceration (? - ? degrees);whether uterine rupture;whether postpartum hemorrhage, ;whether neonatal asphyxia;Apgar score;neonatal blood gas analysis;whether newborns need to be admitted to NICU (cause, diagnosis);whether newborns die;whether mothers die;

Countries

China

Contacts

Public ContactWeizhen Jiang

Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China

wz_jiang2012@163.com+86 133 4887 3346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026